Home LiteratureArticle Details
PMID: 42425763 Published · epublish English

Vav2 is a master regulator of repair against bacterial pore-forming toxins.

Life science alliance ·Vol. 9 ·No. 9 ·2026-09-00

Kayejo VG, Hensley A, Katore T, Keyel PA

Abstract

Despite antibiotic therapy, 25-35% of patients with necrotizing soft tissue infections (NSTIs) die. The etiologic agents for NSTIs include Streptococcus pyogenes and Clostridium perfringens, which secrete the cholesterol-dependent cytolysins (CDCs) streptolysin O and perfringolysin O to disrupt cell membranes. Whereas cells resist this damage by activating Ca2+-dependent repair pathways, including mitogen-activated protein kinase kinase (MEK)-dependent microvesicle shedding, dysferlin-mediated patch repair, and annexin-mediated membrane clogging, the upstream regulators of these responses have remained elusive. Here, we demonstrated that the Rac guanine nucleotide exchange factor Vav2 accounts for almost all of Ca2+-dependent repair against CDCs. Inhibiting or knocking down Vav2 sensitized multiple cell types to CDCs, whereas blocking other Rac guanine nucleotide exchange factors did not. Mechanistically, Vav2 triggered the critical mixed lineage kinase 3-MEK-dependent repair pathway. MEK activation rescued repair in Vav2-inhibited cells. Blocking dysferlin or annexins failed to increase damage beyond Vav2 inhibition, suggesting Vav2 coordinates multiple repair pathways. Thus, Vav2 controls multiple Ca2+-activated repair pathways that protect cells from CDCs produced during NSTIs.

Article Info
Journal
Life science alliance
Abbr.
Life Sci Alliance
ISSN
2575-1077
Published
2026-09-00
Language
English
Country/Region
United States
NLM ID
101728869
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]